617 related articles for article (PubMed ID: 28207746)
21. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene.
Büeler H; Raeber A; Sailer A; Fischer M; Aguzzi A; Weissmann C
Mol Med; 1994 Nov; 1(1):19-30. PubMed ID: 8790598
[TBL] [Abstract][Full Text] [Related]
22. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.
Telling GC; Parchi P; DeArmond SJ; Cortelli P; Montagna P; Gabizon R; Mastrianni J; Lugaresi E; Gambetti P; Prusiner SB
Science; 1996 Dec; 274(5295):2079-82. PubMed ID: 8953038
[TBL] [Abstract][Full Text] [Related]
23. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice.
Supattapone S; Bosque P; Muramoto T; Wille H; Aagaard C; Peretz D; Nguyen HO; Heinrich C; Torchia M; Safar J; Cohen FE; DeArmond SJ; Prusiner SB; Scott M
Cell; 1999 Mar; 96(6):869-78. PubMed ID: 10102274
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.
Collinge J; Sidle KC; Meads J; Ironside J; Hill AF
Nature; 1996 Oct; 383(6602):685-90. PubMed ID: 8878476
[TBL] [Abstract][Full Text] [Related]
25. BSE: can we predict the future?
Plum J
Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
[TBL] [Abstract][Full Text] [Related]
26. Thermostability as a highly dependent prion strain feature.
Marín-Moreno A; Aguilar-Calvo P; Moudjou M; Espinosa JC; Béringue V; Torres JM
Sci Rep; 2019 Aug; 9(1):11396. PubMed ID: 31388046
[TBL] [Abstract][Full Text] [Related]
27. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
28. Prion replication environment defines the fate of prion strain adaptation.
Katorcha E; Gonzalez-Montalban N; Makarava N; Kovacs GG; Baskakov IV
PLoS Pathog; 2018 Jun; 14(6):e1007093. PubMed ID: 29928047
[TBL] [Abstract][Full Text] [Related]
29. Generating a prion with bacterially expressed recombinant prion protein.
Wang F; Wang X; Yuan CG; Ma J
Science; 2010 Feb; 327(5969):1132-5. PubMed ID: 20110469
[TBL] [Abstract][Full Text] [Related]
30. Prions: pathogenesis and reverse genetics.
Aguzzi A; Klein MA; Montrasio F; Pekarik V; Brandner S; Furukawa H; Käser P; Röckl C; Glatzel M
Ann N Y Acad Sci; 2000; 920():140-57. PubMed ID: 11193143
[TBL] [Abstract][Full Text] [Related]
31. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
32. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
33. Cellular prion protein is expressed on peripheral blood mononuclear cells but not platelets of normal and scrapie-infected sheep.
Herrmann LM; Davis WC; Knowles DP; Wardrop KJ; Sy MS; Gambetti P; O' Rourke KI
Haematologica; 2001 Feb; 86(2):146-53. PubMed ID: 11224483
[TBL] [Abstract][Full Text] [Related]
34. Subclinical prion disease induced by oral inoculation.
Thackray AM; Klein MA; Bujdoso R
J Virol; 2003 Jul; 77(14):7991-8. PubMed ID: 12829838
[TBL] [Abstract][Full Text] [Related]
35. Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc.
Foliaki ST; Lewis V; Islam AMT; Ellett LJ; Senesi M; Finkelstein DI; Roberts B; Lawson VA; Adlard PA; Collins SJ
PLoS Pathog; 2019 Apr; 15(4):e1007712. PubMed ID: 30970042
[TBL] [Abstract][Full Text] [Related]
36. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
[TBL] [Abstract][Full Text] [Related]
37. Proteinase K and the structure of PrPSc: The good, the bad and the ugly.
Silva CJ; Vázquez-Fernández E; Onisko B; Requena JR
Virus Res; 2015 Sep; 207():120-6. PubMed ID: 25816779
[TBL] [Abstract][Full Text] [Related]
38. Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates.
Groveman BR; Raymond GJ; Campbell KJ; Race B; Raymond LD; Hughson AG; Orrú CD; Kraus A; Phillips K; Caughey B
PLoS Pathog; 2017 Sep; 13(9):e1006623. PubMed ID: 28910420
[TBL] [Abstract][Full Text] [Related]
39. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.
Rodríguez-Martínez AB; Garrido JM; Zarranz JJ; Arteagoitia JM; de Pancorbo MM; Atarés B; Bilbao MJ; Ferrer I; Juste RA
BMC Neurol; 2010 Oct; 10():99. PubMed ID: 20973975
[TBL] [Abstract][Full Text] [Related]
40. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains.
Yuan J; Xiao X; McGeehan J; Dong Z; Cali I; Fujioka H; Kong Q; Kneale G; Gambetti P; Zou WQ
J Biol Chem; 2006 Nov; 281(46):34848-58. PubMed ID: 16987816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
